홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Hydrochloric Acid → (1S,2S,6R,14R,15S,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol;hydrochloride

HRID 1037630
노트
인쇄 미리보기

반응식

HRID 1037630 반응식
[ClH:1].[CH3:2][C@@:3]([OH:35])([C:31]([CH3:34])([CH3:33])[CH3:32])[C@@H:4]1[C@:9]2([O:29][CH3:30])[C@@H:10]3[O:24][C:19]4=[C:20]([OH:23])[CH:21]=[CH:22][C:17]5=[C:18]4[C@:11]43[CH2:12][CH2:13][N:14]([CH2:25][CH:26]3[CH2:28][CH2:27]3)[C@H:15]([CH2:16]5)[C@@:6]4([CH2:7][CH2:8]2)[CH2:5]1>CC(C)=O>[CH3:2][C@@:3]([OH:35])([C:31]([CH3:34])([CH3:33])[CH3:32])[C@@H:4]1[C@:9]2([O:29][CH3:30])[C@@H:10]3[O:24][C:19]4=[C:20]([OH:23])[CH:21]=[CH:22][C:17]5=[C:18]4[C@:11]43[CH2:12][CH2:13][N:14]([CH2:25][CH:26]3[CH2:27][CH2:28]3)[C@H:15]([CH2:16]5)[C@@:6]4([CH2:7][CH2:8]2)[CH2:5]1.[ClH:1]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 313Hydrochloric AcidHCID 9848990Buprenorphine component OF alks-5461

생성물 1

HCID 9848989(1S,2S,6R,14R,15S,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol;hydrochloride

시약·촉매·용매 1

HCID 180Acetone용매

실험 절차

Conc. HCl (2.6 L) was added to the filtered solution of buprenorphine base (9.65 Kg) in acetone (68 L) at below 15° C. to get pH below 2.0 and stirred for 1.0-2.0 hrs. The HCl salt firmed was filtered, washed with acetone and finally leached with filtered DM water (28 L) at 80° C. and dried. Yield=8.42 Kg.

후처리

  1. customto get pH below 2.0
  2. filtrationThe HCl salt firmed was filtered
  3. washwashed with acetone
  4. customfinally leached with filtered DM water (28 L) at 80° C.
  5. customdried

출처 및 근거

ORD 기록
ord-24f32c6732c940fa87e77ddab1cb1687
출처 데이터셋
uspto-grants-2013_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08546572B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트